Wen, D.; Chen, B.; Deng, M.; Wu, S.; Xie, S.
Plasma Protein Binding, Biostability, Metabolite Profiling, and CYP450 Phenotype of TPB15 Across Different Species: A Novel Smoothened Inhibitor for TNBC Therapy. Pharmaceutics 2025, 17, 423.
https://doi.org/10.3390/pharmaceutics17040423
AMA Style
Wen D, Chen B, Deng M, Wu S, Xie S.
Plasma Protein Binding, Biostability, Metabolite Profiling, and CYP450 Phenotype of TPB15 Across Different Species: A Novel Smoothened Inhibitor for TNBC Therapy. Pharmaceutics. 2025; 17(4):423.
https://doi.org/10.3390/pharmaceutics17040423
Chicago/Turabian Style
Wen, Dingsheng, Boyu Chen, Mingtong Deng, Shaoyu Wu, and Shuilin Xie.
2025. "Plasma Protein Binding, Biostability, Metabolite Profiling, and CYP450 Phenotype of TPB15 Across Different Species: A Novel Smoothened Inhibitor for TNBC Therapy" Pharmaceutics 17, no. 4: 423.
https://doi.org/10.3390/pharmaceutics17040423
APA Style
Wen, D., Chen, B., Deng, M., Wu, S., & Xie, S.
(2025). Plasma Protein Binding, Biostability, Metabolite Profiling, and CYP450 Phenotype of TPB15 Across Different Species: A Novel Smoothened Inhibitor for TNBC Therapy. Pharmaceutics, 17(4), 423.
https://doi.org/10.3390/pharmaceutics17040423